Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
This study is currently recruiting participants.
Verified January 2012
by Jennerex Biotherapeutics
Study NCT01394939 Information provided by Jennerex Biotherapeutics
First Received on July 13, 2011. Last Updated on April 22, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Carcinoma
CRC
Additional conditions recognized in this trial
Carcinoma
Colorectal Neoplasms
Vaccinia
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
DNA Virus Infections
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Poxviridae Infections
Rectal Diseases
Virus Diseases
Interventions listed in this trial
JX-594
Irinotecan
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Topoisomerase I Inhibitors
Topoisomerase Inhibitors
Sponsors listed in this trial
Jennerex Biotherapeutics
Transgene
Back to top of Main Content
